It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
Author
Rapaport, Franck 1 ; Seier, Kenneth 2 ; Neelamraju, Yaseswini 3 ; Hassane, Duane 4 ; Baslan, Timour 5 ; Gildea, Daniel T. 3 ; Haddox, Samuel 3 ; Lee, Tak 4 ; Murdock, H. Moses 6
; Sheridan, Caroline 4 ; Thurmond, Alexis 3 ; Wang, Ling 4 ; Carroll, Martin 6 ; Cripe, Larry D. 7 ; Fernandez, Hugo 8 ; Mason, Christopher E. 9 ; Paietta, Elisabeth 10 ; Roboz, Gail J. 11 ; Sun, Zhuoxin 12 ; Tallman, Martin S. 13 ; Zhang, Yanming 14 ; Gönen, Mithat 2 ; Levine, Ross 15
; Melnick, Ari M. 4
; Kleppe, Maria 15 ; Garrett-Bakelman, Francine E. 16
1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); The Rockefeller University, Center for Clinical and Translational Science, New York, USA (GRID:grid.134907.8) (ISNI:0000 0001 2166 1519)
2 Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
3 University of Virginia, Department of Biochemistry and Molecular Genetics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
4 Weill Cornell Medicine, Division of Hematology and Medical Oncology, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
5 Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
6 University of Pennsylvania Perelman School of Medicine, Division of Hematology and Oncology, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
7 Indiana University, Simon Cancer Center, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
8 Moffitt Cancer Center, Department of Malignant Hematology & Cellular Therapy, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233)
9 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Institute for Computational Biomedicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, The WorldQuant Initiative for Quantitative Prediction, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
10 Montefiore Medical Center, Bronx, USA (GRID:grid.240283.f) (ISNI:0000 0001 2152 0791)
11 Weill Cornell Medicine and The New York Presbyterian Hospital, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
12 Dana-Farber Cancer Institute, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
13 Memorial Sloan Kettering Cancer Center, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
14 Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
15 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
16 University of Virginia, Department of Biochemistry and Molecular Genetics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); Weill Cornell Medicine, Division of Hematology and Medical Oncology, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); University of Virginia, Department of Medicine, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); University of Virginia Cancer Center, Charlottesville, USA (GRID:grid.516071.4) (ISNI:0000 0005 0282 457X)




1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); The Rockefeller University, Center for Clinical and Translational Science, New York, USA (GRID:grid.134907.8) (ISNI:0000 0001 2166 1519)
2 Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
3 University of Virginia, Department of Biochemistry and Molecular Genetics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
4 Weill Cornell Medicine, Division of Hematology and Medical Oncology, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
5 Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
6 University of Pennsylvania Perelman School of Medicine, Division of Hematology and Oncology, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
7 Indiana University, Simon Cancer Center, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
8 Moffitt Cancer Center, Department of Malignant Hematology & Cellular Therapy, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233)
9 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Institute for Computational Biomedicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, The WorldQuant Initiative for Quantitative Prediction, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
10 Montefiore Medical Center, Bronx, USA (GRID:grid.240283.f) (ISNI:0000 0001 2152 0791)
11 Weill Cornell Medicine and The New York Presbyterian Hospital, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
12 Dana-Farber Cancer Institute, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
13 Memorial Sloan Kettering Cancer Center, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
14 Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
15 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
16 University of Virginia, Department of Biochemistry and Molecular Genetics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); Weill Cornell Medicine, Division of Hematology and Medical Oncology, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); University of Virginia, Department of Medicine, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); University of Virginia Cancer Center, Charlottesville, USA (GRID:grid.516071.4) (ISNI:0000 0005 0282 457X)
Pages
103
Publication year
2023
Publication date
Dec 2023
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2833377859
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.